Pricing Log in Create free account
Saturday 17 October 2026 Export SOLV’s income statement to Excel — free account

Solventum Corporation

SOLV Healthcare Medical Instruments & Supplies

Solventum Corporation’s revenue for fiscal 2025 (year ended December 2025) was $8.3 billion, up 0.86% from fiscal 2024. In the quarter to June 2026, revenue grew 2.22%, EPS grew 1.92%, free cash flow grew 144.1% and total debt fell 32.4%, each against the same quarter a year earlier. Member of the S&P 500; revenue growth for three consecutive years; insiders bought in the last twelve months.

85.81 2.05 −2.33%
Market cap
$15.0B
P/E
10.4×
Fwd P/E
39.0×
Dividend yield
—
F-score
5/9
Altman Z
2.22
Beneish M
−2.07
Dividend safety
n/a
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

Solventum Corporation (SOLV) EV/EBITDA

Alert me on EV/EBITDA

As of 16 October 2026, Solventum Corporation (SOLV) trades at a EV/EBITDA of 7.6×. Over the past ten years it has ranged from 5.2× (March 2024) to 16.1× (July 2025); the current reading is higher than 37% of that period. That is below the Medical Instruments & Supplies industry median of 14.6× and below the Healthcare sector median of 9.2×.

EV/EBITDA, daily

Embed this chart

Annual newest first

Period EV/EBITDA Change
FY2025 6.8× (42.44%)
FY2024 11.7× 94.29%
FY2023 6.0× 0.00%
FY2022 6.0× —

Quarterly newest first

Period EV/EBITDA Change
Jun 2026 7.1× 14.04%
Mar 2026 6.2× (8.55%)
Dec 2025 6.8× 12.45%
Sep 2025 6.0× (61.78%)
10 more quarters

Against its own ten years

Low 5.2× High 16.1×
Ten-year median 8.1×
Current reading's percentile 37

EV/EBITDA against peers

Company EV/EBITDA
SOLV Solventum Corporation 7.6×
ATR AptarGroup, Inc. compare 11.6×
ALGN Align Technology, Inc. compare 11.8×
ALC Alcon compare 13.0×
BAX Baxter International Inc. compare 14.0×
COO The Cooper Companies, Inc. compare 14.6×
WST West Pharmaceutical Services, Inc. compare 31.2×
RGEN Repligen Corporation compare 60.2×
AVTR Avantor, Inc. compare 116×
Medical Instruments & Supplies industry median 14.6×
Healthcare sector median 9.2×
Market median 11.0×

What EV/EBITDA is

Enterprise Value over EBITDA tells an investor how the market values a whole company, with debt added and cash taken off, against its operating earnings.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ EBITDA (TTM)

The full definition of EV/EBITDA →

More on SOLV